| IMC-002(Immuneoncia) | IMC-002; 3D-197; 3D197 | Phase 3 Clinical | Immuneoncia Therapeutics Inc | Hematologic Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasms; Neuromyelitis Optica; Solid tumours; Stomach Neoplasms | 詳細 |
| Timdarpacept | IMM01; IMM 01; IMC-001 | Phase 3 Clinical | | Atherosclerosis; Cardiovascular Diseases; Hematologic Neoplasms; Hodgkin Disease; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Leukemia, Promyelocytic, Acute; Lymphoma; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms; Solid tumours | 詳細 |
| Evorpacept | ALX148; ALX-148 | Phase 3 Clinical | Alexo Therapeutics | Carcinoma, Transitional Cell; Composite Lymphoma; Esophageal Neoplasms; Head and Neck Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Metastatic breast cancer; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasm Metastasis; Neoplasms; Oropharyngeal Neoplasms; Plasmablastic Lymphoma; Primary mediastinal B cell lymphoma; Richter's Syndrome; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Urinary Bladder Neoplasms | 詳細 |
| Amulirafusp alfa | IMC-002; IMM-0306 | Phase 3 Clinical | | Glomerulonephritis, Membranous; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Nephrosis; Neuromyelitis Optica | 詳細 |
| Ligufalimab | AK-117 | Phase 3 Clinical | | Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Esophageal Neoplasms; Hodgkin Disease; Leukemia, Myeloid, Acute; Lymphoma; Myelodysplastic Syndromes; Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms | 詳細 |
| Magrolimab | 5F9; Hu5F9-G4; ONO-7913; GS-4721 | Phase 2 Clinical | Stanford University | Brain Neoplasms; Carcinoma, Transitional Cell; Colorectal Neoplasms; Hodgkin Disease; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Multiple Myeloma; Mycosis Fungoides; Myelodysplastic Syndromes; Neuroblastoma; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Sezary Syndrome; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms | 詳細 |
| AO-176 | AO-176; Ti-104; Ti-108; Ti-176 | Phase 2 Clinical | Arch Oncology Inc | Multiple Myeloma; Solid tumours | 詳細 |
| Ontorpacept | TTI-621 | Phase 2 Clinical | The Hospital For Sick Children, Trillium Therapeutics Inc, University Health Network (Uhn) | Breast Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Hematologic Neoplasms; Leiomyosarcoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Melanoma; Multiple Myeloma; Mycosis Fungoides; Papillomavirus Infections; Primary mediastinal B cell lymphoma; Sarcoma; Skin Neoplasms; Solid tumours | 詳細 |
| AUR-103 | AUR-103 | Phase 2 Clinical | Aurigene | Gastroesophageal Junction Neoplasms; Leukemia; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Solid tumours; Stomach Neoplasms | 詳細 |
| Maplirpacept | TTI-622; PF-07901801 | Phase 2 Clinical | Trillium Therapeutics Inc | Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Hematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Multiple Myeloma; Ovarian Neoplasms; Peritoneal Neoplasms; Primary mediastinal B cell lymphoma; Skin Neoplasms | 詳細 |
| DSP-107 | KAHR-107; DSP-107 | Phase 2 Clinical | Kahr Medical | Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Solid tumours | 詳細 |
| BRB-002 | BRB-002 | Phase 2 Clinical | Bitterroot Bio Inc | Atherosclerosis; Cardiovascular Diseases; Vasculitis | 詳細 |
| HCB-101 | HCB-101 | Phase 2 Clinical | HanchorBio Inc | Carcinoma, Renal Cell; Colorectal Neoplasms; Lymphoma, Non-Hodgkin; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms | 詳細 |
| LB-101 (Centessa Pharmaceuticals) | LB-101 (Centessa Pharmaceuticals); LB-101 Tetravalent PD-L1xCD47 LockBody bispecific monoclonal antibody | Phase 2 Clinical | Centessa Pharmaceuticals Plc | | 詳細 |
| Spevatamig | PT-886; PT886 | Phase 2 Clinical | Phanes Therapeutics Inc | Biliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms | 詳細 |
| Peluntamig | PT-217 | Phase 2 Clinical | Phanes Therapeutics Inc | Carcinoma, Neuroendocrine; Neuroendocrine Carcinoma of Lung; Prostatic Neoplasms; Small Cell Lung Carcinoma; Solid tumours | 詳細 |
| BCD-106 | BCD-106 | Phase 2 Clinical | BIOCAD JSC | | 詳細 |
| BAT-7104 | BAT-7104 | Phase 2 Clinical | Bio-Thera Solutions Ltd | | 詳細 |
| IMM-2902 | IMM-2902 | Phase 2 Clinical | | Breast Neoplasms; Cholangiocarcinoma; Lung Neoplasms; Solid tumours; Stomach Neoplasms | 詳細 |
| 6MW-3211 | 6MW3211; 6MW-3211 | Phase 2 Clinical | Mabwell (Shanghai) Bioscience Co Ltd | Carcinoma, Renal Cell; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Myelodysplastic Syndromes; Neoplasms | 詳細 |
| JMT-601 | JMT-601 | Phase 2 Clinical | Shanghai Jmt-Bio Inc | Glomerulonephritis, Membranous; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Nephrosis | 詳細 |
| Lemzoparlimab | ABBV-IMAB-TJC4; TJ-1133; TJ-011133; TJC-4 | Phase 2 Clinical | Abbvie Inc, I-Mab Biopharma Co Ltd | Hematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes; Solid tumours | 詳細 |
| Anti-CD47 monoclonal antibody (Biocad) | | Phase 1 Clinical | BIOCAD JSC | | 詳細 |
| Recombinant humanized monoclonal antibody MIL95 (Mabworks/Connaught Biomedical Technology) | MIL-95; CM-312 | Phase 1 Clinical | Beijing Mabworks Biotech Co Ltd | Leukemia, Myeloid, Acute; Lymphoma; Neoplasms; Solid tumours | 詳細 |
| Zeripatamig | TG-1801; NI-1701 | Phase 1 Clinical | Novimmune Sa | Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Richter's Syndrome | 詳細 |
| SL-172154 | SL-172154; SIRPα -Fc-CD40L | Phase 1 Clinical | Shattuck Labs Inc | Carcinoma, Ovarian Epithelial; Carcinoma, Squamous Cell; Fallopian Tube Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Ovarian Neoplasms; Peritoneal Neoplasms; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| Simridarlimab | IBI-322; IBI322 | Phase 1 Clinical | | Bone Marrow Neoplasms; Hematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, T-Cell; Neoplasms; Solid tumours | 詳細 |
| anti-CD47 mAb (Hangzhou Sumgen Biotechnology/Zhongsheng Sumgen Biotechnology) | SG-404 (Hangzhou Sumgen) | Phase 1 Clinical | Zhongsheng Shangjian Biological Medicine (Hangzhou) Co Ltd | Hematologic Neoplasms; Solid tumours | 詳細 |
| anti-CD47/CD20 bispecific antibody (Bristol-Myers Squibb Co) | | Phase 1 Clinical | Bristol-Myers Squibb Company | Hematologic Neoplasms; Lymphoma, Non-Hodgkin | 詳細 |
| ZL-1201 | ZL-1201 | Phase 1 Clinical | Zai Lab (Shanghai) Co Ltd | Hematologic Neoplasms; Neoplasms; Solid tumours | 詳細 |
| HMPL-A83 | HMPL-A-83; HMPL-A83 | Phase 1 Clinical | | Hematologic Neoplasms; Neoplasms; Solid tumours | 詳細 |
| NI-1801 | NI-1801 | Phase 1 Clinical | Light Chain Bioscience Ltd | Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| IMM-0306S | IMM0306S; IMM-0306S | Phase 1 Clinical | | Lupus Erythematosus, Systemic | 詳細 |
| AK-132 | AK132; AK-132 | Phase 1 Clinical | | | 詳細 |
| D3L-001 | D3L-001 | Phase 1 Clinical | D3 Bio (Wuxi) Co Ltd | | 詳細 |
| FP-002 (Fapon Biopharma) | FP-002 | Phase 1 Clinical | Guangdong Fapon Biopharma Inc | | 詳細 |
| BC-007 (Dragonboat Biopharmaceutical) | BC-007 | Phase 1 Clinical | Dragonboat Biopharmaceutical | | 詳細 |
| SG-1906 | SG-1906; SG1906 | Phase 1 Clinical | Hangzhou Shangjian Biotechnology Co Ltd | | 詳細 |
| LD-002 | LD-002 | Phase 1 Clinical | Zhejiang Blue Shield Pharmaceutical Co Ltd | Hematologic Neoplasms; Lymphoma, Non-Hodgkin; Solid tumours | 詳細 |
| SHS-009 | SHS-009; SH009; SH-009 | Phase 1 Clinical | Nanjing Sanhome Pharmaceutical Co Ltd | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Liver Neoplasms; Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms | 詳細 |
| Monoclonal Antibody (Mab) sB24M | | Phase 1 Clinical | Swiss Biopharma Med GmbH | Pyoderma; Pyoderma Gangrenosum | 詳細 |
| IMM-2520 | IMM-2520 | Phase 1 Clinical | | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| STI-6643 | STI-6643 | Phase 1 Clinical | Sorrento Therapeutics Inc | | 詳細 |
| PF-07257876 | | Phase 1 Clinical | Pfizer Inc | Carcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| TQB-2928 | TQB-2928 | Phase 1 Clinical | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Carcinoma, Non-Small-Cell Lung; Hematologic Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms; Osteosarcoma; Solid tumours | 詳細 |
| IMM2505 | IMM2505; IMM-2505 | Phase 1 Clinical | SunHo (China) BioPharmaceutical Co Ltd | | 詳細 |
| SG404 | SG-404; SG404 | Phase 1 Clinical | Hangzhou Shangjian Biotechnology Co Ltd | | 詳細 |
| Kintuzumab(GenSci) | | Phase 1 Clinical | Changchun GeneScience Pharmaceuticals Co Ltd | Hematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Solid tumours | 詳細 |